Healthcare Opportunity

Menu
  • Biotechnology
  • Healthcare IT
  • Medical Devices
  • Pharmaceuticals
  • About Us
  • Contact Us
Trending News:
  • AbbVie’s psoriasis treatment drug wins first U.S. FDA approval
  • Merck’s Keytruda obtains FDA approval as a kidney cancer therapy
  • Torrent Pharma recalls 1.7M Losartan bottles from the US & Puerto Rico
  • Innovent successfully doses first patient for the treatment of wet AMD
J&J to pay ₹75 lakh to patient in compensation for faulty hip implant

J&J to pay ₹75 lakh to patient in compensation for faulty hip implant

Mateen Dalal Mar 11, 2019 Medical Devices
The compensation order for J&J’s faulty hip implants is a major breakthrough for suffering patients The American healthcare giant, Johnson & Johnson (J&J), has reportedly been commanded by India’s …
Read More >>
Wize Pharma, Cannabics partner to develop cannabinoid-based therapies

Wize Pharma, Cannabics partner to develop cannabinoid-based therapies

Akshay Kedari Mar 8, 2019 Pharmaceuticals
The new joint venture will be dedicated towards the research and development of cannabinoid formulations for treating ophthalmic disorders and address significant unmet medical needs in the market A …
Read More >>
Samsung Health to feature Calm’s sleep tracking and meditation tool

Samsung Health to feature Calm’s sleep tracking and meditation tool

Mateen Dalal Mar 7, 2019 Healthcare IT
The feature will initially be available on Samsung’s Android Pie OS supporting smartphones and will launch in 10 markets globally. Samsung’s health tracking app, Samsung Health is reportedly collaborating …
Read More >>
Eli Lilly offers generic version of its insulin Humalog at half-price

Eli Lilly offers generic version of its insulin Humalog at half-price

Mateen Dalal Mar 5, 2019 Pharmaceuticals
Pharmaceutical giant Eli Lilly has hit the headlines after company’s Chairman and CEO Dave Ricks  publicized the launch of an affordable version of Humalog, its rapid-acting insulin brand. Eli …
Read More >>
Principia Biopharma’s Phase 2 trial exhibits positive results

Principia Biopharma’s Phase 2 trial exhibits positive results

Akshay Kedari Mar 4, 2019 Biotechnology
The latest results indicate a promising risk-benefit profile in all pemphigus patients Principia Biopharma now intends to confirm these results through the current Phase 3 PEGASUS study Principia Biopharma …
Read More >>
FDA grants Orphan Drug Designation to Ascendis Pharma’s TransCon CNP

FDA grants Orphan Drug Designation to Ascendis Pharma’s TransCon CNP

Mateen Dalal Mar 2, 2019 Pharmaceuticals
In accordance with the preliminary results, the company looks forward to a Phase 2 trial by this year’s third quarter, in kids with achondroplasia. Ascendis Pharma A/S, the Denmark-based, …
Read More >>
CEPI to develop vaccine printing technology with biotech firm CureVac

CEPI to develop vaccine printing technology with biotech firm CureVac

Akshay Kedari Mar 1, 2019 Biotechnology
CureVac’s vaccine platform has the potential to improve CEPI’s ability to respond to the emerging Disease X, claims CEPI CEO. In a move to defeat the next pandemic, the …
Read More >>
AstraZeneca's pancreatic cancer drug meets target in late-stage study

AstraZeneca’s pancreatic cancer drug meets target in late-stage study

Akshay Kedari Feb 28, 2019 Pharmaceuticals
Lynparza was the first PARP drug to reach the market after it was approved for ovarian cancer in U.S. Leading multinational pharmaceutical and biopharmaceutical firm, AstraZeneca Plc., has recently …
Read More >>
TAS-102 receives FDA approval for treating adults with GEJ cancer

TAS-102 receives FDA approval for treating adults with GEJ cancer

Mateen Dalal Feb 27, 2019 Pharmaceuticals
The U.S. Food & Drug Administration (FDA) has reportedly approved TAS-102 (trifluridine/tipiracil; Lonsurf, Taiho Oncology) for the treatment of adult patients afflicted with metastatic GEJ (gastroesophageal junction) adenocarcinoma. Reportedly, …
Read More >>
Eyenovia attains confirmatory results from MicroStat Phase III study

Eyenovia attains confirmatory results from MicroStat Phase III study

Akshay Kedari Feb 26, 2019 Pharmaceuticals
Eyenovia, Inc., has reportedly declared attaining positive results from its second MicroStat Phase III study, known as MIST-2. If reports are to be believed this study evaluated the efficacy …
Read More >>

Posts navigation

Previous 1 2 3 4 5 6 7 … 13 Next

Search

Our Contributors

Mateen Dalal

Mateen Dalal

Akshay Kedari

Akshay Kedari

AbbVie's psoriasis treatment drug wins first U.S. FDA approval

AbbVie’s psoriasis treatment drug wins first U.S. FDA approval

Merck’s Keytruda obtains FDA approval as a kidney cancer therapy

Merck’s Keytruda obtains FDA approval as a kidney cancer therapy

Torrent Pharma recalls 1.7M Losartan bottles from the US & Puerto Rico

Torrent Pharma recalls 1.7M Losartan bottles from the US & Puerto Rico

Innovent successfully doses first patient for the treatment of wet AMD

Innovent successfully doses first patient for the treatment of wet AMD

Wave Life Sciences unveils key data from Phase 1 study of suvodirsen

Wave Life Sciences unveils key data from Phase 1 study of suvodirsen

Cipla & Pulmatrix sign pact to co-develop and commercialize Pulmazole

Cipla & Pulmatrix sign pact to co-develop and commercialize Pulmazole

Healthcare Opportunity Copyright © 2021.
  • About Us
  • Contact Us
  • Our Team
  • Privacy Policy
  • Editorial Policy
Physical address:
We are moving...
We will update our new address soon.
Mail: [email protected]